HCPCS Level II code J1320 denotes an injection of amitriptyline hydrochloride up to 20 mg. Nationally, this code captures billing for parenteral administration of a tricyclic antidepressant formulation used in specific clinical circumstances, often when oral therapy is not feasible. Accurate coding of J1320 affects billing clarity for outpatient clinics, infusion centers, and physician offices that administer medication injections.

Key payers in the coverage landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a synthesis of relevance for these payers, including coverage considerations and common billing practices reported for medication injections. The publication provides clinical context for when an injectable amitriptyline product may be used, expected sites of service, and how J1320 is positioned among medication injection codes.

This summary prepares clinicians, billing staff, and policy analysts to understand where J1320 fits in service lines and payer interactions. The full content includes benchmarks where available, documentation expectations, and a concise policy-oriented discussion to support accurate claim submission and programmatic tracking.